GPCR FY 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$288M

Net Income

-$141M

EPS (Diluted)

$-2.40

Cash Flow

Operating Cash Flow

-$222M

Free Cash Flow

-$226M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$68M

Stockholders' Equity

$1.5B

Cash & Equivalents

$800M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	$0	—
Operating Income	-$288M	-$158M	-81.7%
Net Income	-$141M	-$123M	-15.2%